BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Voß F, Kohler TP, Meyer T, Abdullah MR, van Opzeeland FJ, Saleh M, Michalik S, van Selm S, Schmidt F, de Jonge MI, Hammerschmidt S. Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation. Front Immunol 2018;9:2405. [PMID: 30405609 DOI: 10.3389/fimmu.2018.02405] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Voß F, van Beek LF, Schwudke D, Ederveen THA, van Opzeeland FJ, Thalheim D, Werner S, de Jonge MI, Hammerschmidt S. Lipidation of Pneumococcal Antigens Leads to Improved Immunogenicity and Protection. Vaccines (Basel) 2020;8:E310. [PMID: 32560374 DOI: 10.3390/vaccines8020310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Masomian M, Ahmad Z, Gew LT, Poh CL. Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection. Vaccines (Basel) 2020;8:E132. [PMID: 32192117 DOI: 10.3390/vaccines8010132] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
3 Liu Q, Shen X, Bian X, Kong Q. Effect of deletion of gene cluster involved in synthesis of Enterobacterial common antigen on virulence and immunogenicity of live attenuated Salmonella vaccine when delivering heterologous Streptococcus pneumoniae antigen PspA. BMC Microbiol 2020;20:150. [PMID: 32513100 DOI: 10.1186/s12866-020-01837-0] [Reference Citation Analysis]
4 Jeon JH, Kim YH, Kim KA, Kim YR, Woo SJ, Choi YJ, Rhie GE. A putative exosporium lipoprotein GBAA0190 of Bacillus anthracis as a potential anthrax vaccine candidate. BMC Immunol 2021;22:20. [PMID: 33743606 DOI: 10.1186/s12865-021-00414-y] [Reference Citation Analysis]
5 van Beek LF, Surmann K, van den Berg van Saparoea HB, Houben D, Jong WSP, Hentschker C, Ederveen THA, Mitsi E, Ferreira DM, van Opzeeland F, van der Gaast-de Jongh CE, Joosten I, Völker U, Schmidt F, Luirink J, Diavatopoulos DA, de Jonge MI. Exploring metal availability in the natural niche of Streptococcus pneumoniae to discover potential vaccine antigens. Virulence 2020;11:1310-28. [PMID: 33017224 DOI: 10.1080/21505594.2020.1825908] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mills RO, Abdullah MR, Akwetey SA, Sappor DC, Cole I, Baffuor-Asare M, Bolivar JA, Gámez G, van der Linden MPG, Hammerschmidt S. Post-Vaccination Streptococcus pneumoniae Carriage and Virulence Gene Distribution among Children Less Than Five Years of Age, Cape Coast, Ghana. Microorganisms 2020;8:E1987. [PMID: 33322236 DOI: 10.3390/microorganisms8121987] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Lagousi T, Basdeki P, De Jonge MI, Spoulou V. Understanding host immune responses to pneumococcal proteins in the upper respiratory tract to develop serotype-independent pneumococcal vaccines. Expert Rev Vaccines 2020;19:959-72. [PMID: 33107359 DOI: 10.1080/14760584.2020.1843433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Hirschfeld C, Gómez-Mejia A, Bartel J, Hentschker C, Rohde M, Maaß S, Hammerschmidt S, Becher D. Proteomic Investigation Uncovers Potential Targets and Target Sites of Pneumococcal Serine-Threonine Kinase StkP and Phosphatase PhpP. Front Microbiol 2019;10:3101. [PMID: 32117081 DOI: 10.3389/fmicb.2019.03101] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
9 Seinen J, Engelke R, Abdullah MR, Voß F, Michalik S, Dhople VM, Dieperink W, de Smet AMGA, Völker U, van Dijl JM, Schmidt F, Hammerschmidt S. Sputum Proteome Signatures of Mechanically Ventilated Intensive Care Unit Patients Distinguish Samples with or without Anti-pneumococcal Activity. mSystems 2021;6:e00702-20. [PMID: 33653939 DOI: 10.1128/mSystems.00702-20] [Reference Citation Analysis]
10 Kaplonek P, Yao L, Reppe K, Voß F, Kohler T, Ebner F, Schäfer A, Blohm U, Priegue P, Bräutigam M, Pereira CL, Parameswarappa SG, Emmadi M, Ménová P, Witzenrath M, Hammerschmidt S, Hartmann S, Sander LE, Seeberger PH. A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae. Vaccine 2022:S0264-410X(21)01676-5. [PMID: 35033388 DOI: 10.1016/j.vaccine.2021.12.068] [Reference Citation Analysis]
11 Abdullah MR, Batuecas MT, Jennert F, Voß F, Westhoff P, Kohler TP, Molina R, Hirschmann S, Lalk M, Hermoso JA, Hammerschmidt S. Crystal Structure and Pathophysiological Role of the Pneumococcal Nucleoside-binding Protein PnrA. J Mol Biol 2021;433:166723. [PMID: 33242497 DOI: 10.1016/j.jmb.2020.11.022] [Reference Citation Analysis]
12 Converso TR, Assoni L, André GO, Darrieux M, Leite LCC. The long search for a serotype independent pneumococcal vaccine. Expert Rev Vaccines 2020;19:57-70. [PMID: 31903805 DOI: 10.1080/14760584.2020.1711055] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
13 Kaur R, Pichichero M. Lipidation of Haemophilus influenzae Antigens P6 and OMP26 Improves Immunogenicity and Protection against Nasopharyngeal Colonization and Ear Infection. Infect Immun 2022;:e0067821. [PMID: 35435727 DOI: 10.1128/iai.00678-21] [Reference Citation Analysis]